-
Drug Distributor And Former Execs Face First Criminal Charges In Opioid Crisis
A DEA official said the indictments are meant to send "shock waves" through the pharmaceutical industry to remind it of its responsibility to help control prescription medications. -
Prison For Forced Addiction Treatment? A Parent's 'Last Resort' Has Consequences
Thousands of Massachusetts residents have been committed to treatment for addiction against their will. Some families say locking up addicts in prison isn't treatment. Others say it saves lives. -
Amid Opioid Prescriber Crackdown, Health Officials Reach Out To Pain Patients
After 53 health care workers were indicted for illegally prescribing opioids in Appalachia, local health agencies are trying to make sure chronic pain patients don't fall through the cracks. -
Traveling Art Project Honors Those Lost To Opioid Crisis
The opioid epidemic has touched countless lives. One local project hopes to reduce the stigma of addiction and create awareness, all while sparking conversation. -
Nearly 60 Docs, Other Medical Workers Face Charges In Federal Opioid Sting
The Department of Justice said defendants allegedly pushed millions of pills' worth of unneeded opioids, contributing to a drug crisis and potentially defrauding the health care system. -
Law And Order With Andrea Cabral: Mass. Prisons Now Offer Medication To Treat Inmates' Opiate Addictions
Former Suffolk County Sheriff Andrea Cabral joined Boston Public Radio to talk about how Massachusetts prisons are now offering medication to treat inmates with opiate addictions. -
Family Behind OxyContin Calls Opioid Suit False, Misleading
The family that owns the company that makes OxyContin is calling a Massachusetts lawsuit false and misleading. -
Insys Therapeutics Pushed Opioid With Bribes And Lies, Prosecutors Say
If convicted, Insys Therapeutics founder and onetime billionaire John Kapoor could face up to 20 years behind bars. -
China To Close Loophole On Fentanyl After U.S. Calls For Opioid Action
Some manufacturers evaded scrutiny by slightly modifying the molecular structures of substances. Monday's announcement "puts a wider array of substances under regulation," a Chinese official says. -
Purdue Pharma Reaches $270M Settlement In Oklahoma
The maker of OxyContin and the company's controlling family agreed Tuesday to pay a groundbreaking $270 million to Oklahoma.
